Differences in gender, BMI, diabetes mellitus, background of liver disease, tumor size, tumor number, MVI, BCLC staging, CNLC staging, AFP level, and surgical bleeding were statistically significant among the three groups (P<.05). This evidence concerns the gene AFP and neoplasm.